Acciones Wildflower Marijuana Inc Canadian Securities Exchange
Acciones
CA96812E1051
Farmacéuticos
Ventas 2018 | 1,41 1,93 1,31 | Ventas 2019 | 7,09 9,69 6,58 | Capitalización | 63,9 M 87,41 M 59,34 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -7 M -9,58 M -6,5 M | Resultado Neto 2019 | -4 M -5,47 M -3,71 M | VE / Ventas 2018 | 44.908.398 x |
Deuda neta 2018 | 7,85 M 10,74 M 7,29 M | Deuda neta 2019 | 7,32 M 10,01 M 6,8 M | VE / Ventas 2019 | 10.051.719 x |
P/E ratio 2018 |
-6,99
x | P/E ratio 2019 |
-6,61
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
William MacLean
CEO | Chief Executive Officer | - | 18/06/14 |
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 30/08/13 |
Myron van Snick
COO | Chief Operating Officer | - | 13/04/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 30/08/13 |
William MacLean
CEO | Chief Executive Officer | - | 18/06/14 |
Director/Board Member | - | 06/04/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+39,33 % | 6114,98 M | |
-18,38 % | 4347,02 M | |
-9,17 % | 3191,44 M | |
+3,98 % | 3152,64 M | |
-3,41 % | 2511,02 M | |
+48,74 % | 1983,16 M | |
-4,82 % | 1737,6 M | |
-1,24 % | 1627,08 M | |
-8,96 % | 1602,33 M |